Acute exacerbation of interstitial lung disease after procedures.

Respir Med

Department of Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep, University of Minnesota, Minneapolis, MN, United States. Electronic address:

Published: April 2019

Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2019.02.012DOI Listing

Publication Analysis

Top Keywords

acute exacerbation
12
interstitial lung
8
lung disease
8
acute
4
exacerbation interstitial
4
lung
4
procedures
4
disease procedures
4
procedures interstitial
4
disease ild
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!